These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 6466454)
1. [Characteristics of the electrophoretic mobility of blasts from acute non-lymphoid leukemias]. Pavone V; Specchia G; Jirillo E; Magno M; Liso V Boll Ist Sieroter Milan; 1984 May; 63(2):130-5. PubMed ID: 6466454 [TBL] [Abstract][Full Text] [Related]
3. Hemophagocytosis by leukemic blasts in 7 acute myeloid leukemia cases with t(16;21)(p11;q22): common morphologic characteristics for this type of leukemia. Imashuku S; Hibi S; Sako M; Lin YW; Ikuta K; Nakata Y; Mori T; Iizuka S; Horibe K; Tsunematsu Y Cancer; 2000 Apr; 88(8):1970-5. PubMed ID: 10760776 [TBL] [Abstract][Full Text] [Related]
4. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells. Pattengale PK; Sundstrom C; Yu AL; Levine A Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341 [TBL] [Abstract][Full Text] [Related]
5. CD79 alpha expression in acute myeloid leukemia. High frequency of expression in acute promyelocytic leukemia. Arber DA; Jenkins KA; Slovak ML Am J Pathol; 1996 Oct; 149(4):1105-10. PubMed ID: 8863659 [TBL] [Abstract][Full Text] [Related]
6. [Cytomorphology of acute mixed leukemia]. Sucić M; Batinić D; Zadro R; Mrsić S; Labar B Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415 [TBL] [Abstract][Full Text] [Related]
7. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype. Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721 [TBL] [Abstract][Full Text] [Related]
8. Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia. Donnard M; Guglielmi L; Turlure P; Piguet C; Couraud MJ; Bordessoule D; Denizot Y Stem Cells; 2002; 20(5):394-401. PubMed ID: 12351810 [TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies. Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246 [TBL] [Abstract][Full Text] [Related]
10. Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. Montecucco CM; Riccardi A; Cresci R; Mazzini G; Ascari E Basic Appl Histochem; 1980; 24(4):423-34. PubMed ID: 6934771 [TBL] [Abstract][Full Text] [Related]
11. N-acetyl-beta-glucosaminidase activity in normal and acute leukemia blood cells. Invernizzi R; Girino M; Nano R Basic Appl Histochem; 1981; 25(2):121-7. PubMed ID: 6944065 [TBL] [Abstract][Full Text] [Related]
12. Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates. Kaiserling E; Horny HP; Geerts ML; Schmid U Mod Pathol; 1994 Sep; 7(7):771-9. PubMed ID: 7824512 [TBL] [Abstract][Full Text] [Related]
13. Definition of acute biphenotypic leukemia. Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085 [TBL] [Abstract][Full Text] [Related]
14. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin. Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165 [TBL] [Abstract][Full Text] [Related]
15. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia. Babusíková O; Glasová M; Koníková E; Kusenda J Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560 [TBL] [Abstract][Full Text] [Related]
16. A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII. Kiss F; Simon A; Csáthy L; Hevessy Z; Katona E; Kiss C; Kappelmayer J Cytometry A; 2008 Mar; 73(3):194-201. PubMed ID: 18000871 [TBL] [Abstract][Full Text] [Related]
17. Relation of some cytochemical activities to the expression of CD34 marker in acute leukemia. Klobusická M; Babusíková O; Hrivnáková A Neoplasma; 1993; 40(5):309-14. PubMed ID: 7505888 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells. Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemia. Rice AM; Holtz KM; Karp J; Rollins S; Sartorelli AC Leuk Res; 2004 Nov; 28(11):1227-37. PubMed ID: 15380350 [TBL] [Abstract][Full Text] [Related]
20. High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia. Clavio M; Carrara P; Miglino M; Pierri I; Canepa L; Balleari E; Gatti AM; Cerri R; Celesti L; Vallebella E; Sessarego M; Patrone F; Ghio R; Damasio E; Gobbi M Haematologica; 1996; 81(6):513-20. PubMed ID: 9009438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]